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Abstract
The objectives of this paper are to predict life years lost associated with obesity-related diseases (ORDs) for U.S. non-
smoking adults, and to examine the relationship between those ORDs and mortality. Data from the National Health
Interview Survey, 1997–2000, were used. We employed mixed proportional hazard models to estimate the association
between those ORDs and mortality and used simulations to project life years lost associated with the ORDs. We found that
obesity-attributable comorbidities are associated with large decreases in life years and increases in mortality rates. The life
years lost associated with ORDs is more marked for younger adults than older adults, for blacks than whites, for males than
females, and for the more obese than the less obese. Using U.S. non-smoking adults aged 40 to 49 years as an example to
illustrate percentage of the life years lost associated with ORDs, we found that the mean life years lost associated with ORDs
for U.S. non-smoking black males aged 40 to 49 years with a body mass index above 40 kg/m2 was 5.43 years, which
translates to a 7.5% reduction in total life years. White males of the same age range and same degree of obesity lost 5.23 life
years on average – a 6.8% reduction in total life years, followed by black females (5.04 years, a 6.5% reduction in life years),
and white females (4.7 years, a 5.8% reduction in life years). Overall, ORDs increased chances of dying and lessened life years
by 0.2 to 11.7 years depending on gender, race, BMI classification, and age.
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Introduction
The increasing prevalence of overweight and obesity has caused
an increased risk of obesity-related comorbidities. These obesity-
related diseases (ORDs) include serious chronic diseases, such as
coronary heart disease, hypertension, type 2 diabetes, stroke,
dyslipidemia, and some cancers, such as endometrial, breast, colon
cancers [1,2], and multiple myeloma [3]. The rising trend of
ORDs has not only increased annual medical spending [4,5] but
also increased the risks of mortality. The Centers for Disease
Control and Prevention (CDC) estimates that approximately
112,000 deaths are associated with obesity each year in the United
States [6,7].
A large body of literature has studied the relationship between
mortality and obesity [8–27]. However, most of the studies did not
take ORDs into consideration, even though obesity-attributable
comorbidities have been known to add variation to the simple
relationship between mortality risk and body mass index (BMI –
the ratio of weight in kilograms to the height in meters squared)
[25,26,28–32]. In terms of life years measurement, Stevens et al.
[27], Peeters et al. [11], Fontaine et al. [14], and, recently,
Finkelstein et al. [33] attempted to calculate life years lost to
obesity, but did not estimate the change in the life years associated
with ORDs. It is known that not all obese individuals are at a
higher health risk. Moreover, obesity per se does not cause death
directly; it is those diseases associated with obesity that shorten life
years. To our knowledge, none has focused on the incidence of
ORDs or the association of ORDs with mortality and life
expectancy.
Furthermore, most of the published literature studying the
association between BMI and mortality employed Cox Propor-
tional Hazards (PH) models [34]. The problem with using the Cox
PH models is that they do not take into account unobserved
individual heterogeneity, e.g., familial risks, which affects the
outcome; however those data were unavailable to investigators.
Evidence has shown that failing to control for unobserved
heterogeneity results in biased estimation and, consequently,
biased hazard ratios and leads to erroneous conclusions [35–39].
Our study used the Mixed Proportional Hazard (MPH) model
[37], which takes unobserved heterogeneity into account and
therefore presumably provides a more precise estimation [35–38]
than the Cox PH models. The MPH model was preferred in the
duration analysis because individuals with relatively high hazard
rates for unobserved reasons (e.g., people who have family history
of cancer(s) and genetic abnormalities) die earlier on average.
Consequently, samples of survivors are selected [36]. Inferences
based on these selected samples are likely to be biased. We further
extended the estimation results to simulate life years for the group
of individuals with the same characteristics and calculate the life
years lost associated with ORDs. The simulation approach we
employed provides an alternative to the life table approach to
project life years.
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The aims of this study are (i) to examine the relationship
between ORDs and mortality by using the MPH models and data
from a national probability sample of the U.S. civilian noninsti-
tutionalized population; and (ii) to predict life years lost associated
with ORDs using simulated cohorts of the population. The
projection of life years lost is based on the observed characteristics
of the sample between 1997 and 2000 as a snapshot of their life
span, and their characteristics upon survey determines their
predicted life years. Our purpose is to investigate how ORDs in
general observed at different life stages will impact life years for the
target populations, rather than to examine ORDs separately.
Materials and Methods
The Data
Our data were extracted from (i) the National Health Interview
Survey (NHIS) [40]; and (ii) the NHIS Linked Mortality Public-
use Files [41]. The NHIS is a multi-purpose health survey
providing health information on the civilian, noninstitutionalized,
household population of the United States. The NHIS consists of
three major components: Family, Sample Adult, and Sample
Child. From each family in the survey, one sample adult and one
sample child (if any children under age 18 are present) are
randomly selected, and information on each is collected from the
sample adult core and the sample child core questionnaires [42].
This study used the Sample Adult Data Files, which contain data
on adults aged 18 years and older.
Mortality data were extracted from the NHIS Linked Mortality
Public-use Files [41], which provide mortality follow-up data for
the NHIS sample from the date of interview through December
31, 2006 [43]. We linked the individual data in the NHIS Sample
Adult Data Files to the data in the NHIS Linked Mortality files by
personal identification numbers.
The sample in our study was retrieved from NHIS years 1997 to
2000 [44], and the exclusion criteria were as follows: (i) individuals
with any missing data on the target variables; (ii) individuals
smoking over 100 cigarettes in their entire life, because analyses
can be confounded by illnesses associated with smoking
[20,21,45]; (iii) women pregnant at the time of survey, because
BMI levels are unstable during pregnancy; and (iv) patients who
have ever been diagnosed with cancer or a malignancy of any
kind, because their BMI levels are less stable due to the cancer
treatments and appetite loss.
Table 1. Descriptive statistics for U.S. non-smoking adults in the sample and the population, 1997–2000.
Variable na (%) Nb (%) Variable na (%) Nb (%)
Total 61,873 93,853,798 Phy. Actf 31,217 (50.45) 51,464,802 (54.84)
Gender Age at survey
Male 23,518 (38.01) 41,383,588 (44.09) 192 2,174 (3.51) 5,095,174 (5.43)
Female 38,355 (61.99) 52,470,210 (55.91) 20–29 12,865 (20.79) 20,715,096 (22.07)
Race 30–39 15,047 (24.32) 22,390,794 (23.86)
White 46,598 (75.31) 73,640,855 (78.46) 40–49 11,742 (18.98) 18,765,606 (20.00)
Black 9,679 (15.64) 12,379,346 (13.19) 50–59 7,078 (11.44) 10,746,130 (11.45)
Education 60–69 5,152 (8.33) 7,028,974 (7.49)
High schoolc 49,082 (79.33) 78,561,270 (83.71) 70+ 7,815 (12.63) 9,112,022 (9.71)
Under 12,791 (20.67) 15,292,528 (16.29) Age at death
BMI Classification 292 46 (1.15) 89,986 (1.90)
Underweight 1,304 (2.11) 2,023,392 (2.16) 30–34 36 (0.90) 54,090 (1.14)
Normal weight 27,345 (44.20) 40,070,478 (42.69) 35–39 50 (1.24) 73,094 (1.55)
Overweight 20,492 (33.12) 32,360,352 (34.48) 40–44 85 (2.12) 119,106 (2.52)
Class I obese 8,406 (13.09) 12,867,565 (13.71) 45–49 120 (2.99) 178,146 (3.77)
Class II obese 2,773 (4.48) 4,246,025 (4.52) 50–54 118 (2.94) 154,952 (3.28)
Class III obese 1,553 (2.51) 2,285,986 (2.44) 55–59 112 (2.79) 154,217 (3.26)
ORDsd 15,178 (24.53) 20,772,263 (22.13) 60–64 156 (3.88) 194,259 (4.11)
0 46,695 (75.47) 73,081,535 (77.87) 65–69 209 (5.20) 276,619 (5.85)
1 12,003 (19.40) 16,680,111 (17.77) 70–74 299 (7.44) 381,127 (8.06)
2 2,642 (4.27) 3,434,897 (3.66) 75–79 468 (11.65) 556,254 (11.76)
3 474 (0.77) 578,575 (0.62) 80–84 698 (17.38) 766,960 (16.22)
4 59 (0.10) 78,679 (0.08) 85–89 1,144 (28.48) 1,231,868 (26.05)
No alcohole 7,173 (11.59) 10,464,992 (11.15) 90+ 476 (11.85) 498,720 (10.55)
n N Minimum Maximum Mean Standard deviation
BMI (kg/m2) 61,873 93,853,798 6.6 89.9 29.77 16.10
Age at death (years) 4,017 4,729,398 20.0 94.0 76.57 15.01
Source: Authors’ calculations based on data from National Health Interview Survey, 1997–2000.
Notes: a. n: sample size; b. estimated population size; c. high school graduates; d. ORD: obesity-related diseases; e. the individual had had no more than 12 drinks of any
type of alcoholic beverage in the individual’s entire life; f. the individual engaged in physical activities for 10 minutes at least once per week.
doi:10.1371/journal.pone.0066550.t001
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Outcome Variable, Covariates, and Model Specifications
Age at death or censor was the outcome variable. We included
the following covariates in each model: gender, race, educational
attainment, alcohol consumption, and physical activities. For race,
we used dichotomized variables for whites and blacks. We
controlled for educational attainment by using a binary variable
to indicate whether the individual is a high school graduate.
Alcohol consumption is dichotomized by whether an individual
had had no more than 12 drinks of any type of alcoholic beverage
in the individual’s entire life upon survey. Physical activity was
dichotomized by whether the individual was engaged in modest or
vigorous physical activities for 10 minutes at least once per week.
We also examined variables containing ORD information and
constructed an ordinal variable recording the number of ORDs.
The ORDs in our study included coronary heart disease,
hypertension, diabetes, and stroke [46]. In addition, we generated
age dummies delineating an individual’s age at survey. We also
considered a binary variable recording whether individuals
reported that they had at least one ORD. Age dummies included
individuals between ages 20 and 29, 30 and 39, 40 and 49, 50 and
59, 60 and 69, and 70 and above at survey. The reference group
was individuals below 20 years of age.
We considered BMI classifications based on the standards
established by the World Health Organization [47]: underweight
for people whose BMI is less than 18.5 kg/m2; normal if BMI M
[18.5, 25); overweight if BMI M [25, 30); class I obese if BMI M [30,
35), class II obese if BMI M [35, 40), and class III obese if BMI is at
least 40 kg/m2. We also considered BMI level of linear, quadratic
[14,48], and inverted forms [14,19,22].
We tested different model specifications and parametric
assumptions. For the parametric specification, we assumed
different distributions of unobserved heterogeneity and changed
the number of parameters for the baseline hazard. Different
combinations of model specifications and parametric assumptions
were performed. All model specifications considered in our study
are listed in Table S1 in Appendix S1. Our final model was
determined by a weighted Akaike information criterion (WAIC)
because of the complex sampling design in the NHIS data [49].
The following covariates were included in the final model: male,
white, black, high school graduate, the number of ORDs, alcohol
consumption, physical activity, BMI classifications in the form of
binary variables (underweight, overweight, class I, II, and III
obese, where normal-weight was considered the base group), age
dummies, and the interaction terms of age dummies with the
number of ORDs. Model estimation is detailed in Appendix S1.
Prediction of Life Years Lost Associated with ORDs
Life years lost was predicted by simulating life years for
populations with at least one ORD and without ORDs based on
the estimates in the final model. We divided our sample into
groups with different combinations of race, gender, age, and BMI
classification. For each group, we simulated their survival densities
based on the parameter estimates in the final model and predicted
life years. Life years lost was projected by comparing the predicted
life years of people with ORDs to that of people without ORDs
within the same group. The bootstrap method [50,51] was
performed to resample the subpopulations 1,000 times in order to
compute the means and standard errors.
All estimations and bootstraps were adjusted for the complex
sampling design [50–53] in the NHIS [42]. STATA (11, Stata
Corp, College Station, TX) was used to obtain the summary
statistics for the sample and population, and MATLAB (7.13,
R2011b, MathWorks Inc, Natick, MA) was used to perform
estimations and simulations.
Sensitivity Analyses
A probabilistic sensitivity analysis was conducted to explore the
variation in life years lost prediction arising from the parameter
uncertainty in the simulations [54]. We first sampled the
parameters from the distribution of our estimators [52]. For each
set of parameters, we simulated life years and computed the life
years lost associated with ORDs for each subgroup. We repeated
this process 1,000 times and computed the means and standard
errors [55].
Hazard Ratios for Death
We computed the changes in the risk of death at different life
stages associated with an additional ORD. These marginal effects
of ORDs on hazard rate enabled us to explore how an additional
ORD impacted mortality.
Figure 1. Life years lost associated with obesity-related diseases for U.S. white and black, male and female, overweight and obese,
non-smoking adults.
doi:10.1371/journal.pone.0066550.g001
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We also computed hazard ratios for BMI classifications by
dividing the death rates for the underweight, overweight, class I,
II, and III obese by the death rates for the normal-weight. These
hazard ratios allowed us to compare and contrast our findings with
those in previous studies that used other approaches and models.
Results
Descriptive Statistics
Table 1 presents the summary statistics of our sample and the
estimated population. The sample contained 61,873 individuals,
representing a population of 93,853,798 U.S. non-smoking adults.
Among the sample, 38% were male, 75% were white, and 16%
were black. Almost 80% of the sample had a high school degree.
4,017 deaths were identified. The mean age at death was 77 years.
The maximum age in our sample was 94 years. The largest
percentage of people (28%) died between 85 and 89 years of age;
476 people died at age 90 or older.
The average BMI of the sample was 29.77 kg/m2; 2% of the
sample were underweight; 44% of the sample had a BMI within
the normal-weight range; 33% were overweight; 13%, 5%, and
3% of the sample belonged to class I, II, and III obese,
respectively. Approximately 75% of the sample reported no
ORDs before the survey; 19% of the sample reported that they
had one ORD; 4% had two ORDs; and less than 1% of the
sample had at least three ORDs. About 12% of the sample
Table 2. Predicted life years lost associated with obesity-related diseases for U.S. non-smoking adults, 1997–2000a.
White male White female Black male Black female Other male Other female Overall
292 Underweight 6.88 (8.71) 6.75 (4.70) – (–) 7.74 (6.67) 10.12 (11.67) 6.54 (5.52) 7.11 (3.03)
Normal-weight 6.54 (1.57) 5.92 (1.46) 7.48 (3.95) 6.57 (2.12) 6.53 (4.08) 5.06 (2.87) 6.13 (0.89)
Overweight 6.83 (1.29) 5.20 (1.45) 7.25 (2.17) 5.57 (1.71) 6.70 (4.72) 4.90 (2.85) 5.85 (0.70)
Class I obese 7.41 (2.10) 6.00 (1.61) 7.42 (3.63) 6.52 (2.02) 7.60 (4.06) 5.86 (3.30) 6.38 (0.98)
Class II obese 8.59 (2.97) 5.48 (2.91) 9.69 (4.10) 8.11 (3.20) 9.45 (7.24) 5.91 (4.50) 7.44 (1.49)
Class III obese 8.45 (3.94) 8.71 (3.22) 11.65 (5.34) 9.29 (2.99) 8.16 (11.40) 6.05 (9.96) 9.10 (1.75)
Overall 6.94 (0.83) 5.67 (0.79) 7.67 (1.60) 6.81 (0.98) 7.07 (2.20) 5.15 (1.56) 6.24 (0.44)
30–39 Underweight 5.45 (4.29) 4.49 (3.80) – (–) 7.07 (7.22) – (–) – (–) 5.83 (2.60)
Normal-weight 4.85 (0.93) 3.59 (0.67) 5.18 (2.04) 3.96 (1.29) 4.49 (2.60) 3.55 (1.95) 4.12 (0.49)
Overweight 4.26 (0.61) 3.19 (0.78) 5.42 (1.51) 3.78 (1.15) 4.39 (2.04) 3.57 (1.81) 3.85 (0.41)
Class I obese 4.60 (0.85) 3.55 (0.91) 5.32 (1.65) 4.45 (1.32) 4.75 (3.16) 3.49 (2.45) 4.17 (0.50)
Class II obese 5.66 (1.49) 4.16 (1.31) 6.03 (2.74) 4.80 (1.59) 4.87 (3.69) 3.87 (2.93) 4.83 (0.74)
Class III obese 6.17 (2.33) 5.63 (1.56) 6.29 (3.86) 5.67 (1.75) 5.63 (4.63) 3.92 (5.37) 5.97 (1.01)
Overall 4.83 (0.42) 3.84 (0.41) 5.73 (0.88) 4.67 (0.59) 4.88 (1.26) 3.52 (1.00) 4.48 (0.24)
40–49 Underweight 5.75 (5.20) 5.87 (6.28) – (–) 3.09 (8.75) – (–) 4.72 (9.21) 5.90 (3.29)
Normal-weight 4.12 (0.88) 3.43 (0.51) 4.74 (1.99) 3.82 (1.08) 4.51 (2.26) 2.89 (1.68) 3.65 (0.40)
Overweight 3.97 (0.53) 3.27 (0.61) 4.62 (1.24) 3.55 (0.94) 3.96 (1.71) 3.09 (1.62) 3.70 (0.34)
Class I obese 4.18 (0.78) 3.43 (0.67) 4.90 (1.63) 4.08 (1.08) 4.22 (2.63) 3.43 (1.95) 3.83 (0.43)
Class II obese 5.29 (1.21) 4.10 (1.04) 5.17 (3.45) 4.68 (1.94) 3.66 (4.11) 4.07 (2.66) 4.62 (0.67)
Class III obese 5.23 (1.90) 4.70 (1.22) 5.43 (4.89) 5.04 (1.99) 6.34 (5.51) 4.82 (3.27) 5.00 (0.85)
Overall 4.52 (0.36) 3.82 (0.29) 5.00 (0.85) 4.44 (0.54) 4.49 (1.09) 3.68 (0.87) 4.23 (0.19)
50–59 Underweight 3.84 (6.32) 2.82 (3.11) 4.39 (10.37) 5.27 (9.80) – (–) – (–) 4.61 (2.55)
Normal-weight 2.81 (0.86) 2.30 (0.46) 3.92 (1.72) 2.89 (1.15) 3.21 (2.18) 1.96 (1.43) 2.54 (0.35)
Overweight 2.80 (0.55) 2.10 (0.48) 3.34 (1.33) 2.57 (0.98) 2.89 (1.66) 2.12 (1.45) 2.44 (0.32)
Class I obese 2.80 (0.79) 2.41 (0.64) 3.10 (1.97) 2.78 (1.16) 2.83 (3.07) 2.24 (2.19) 2.70 (0.43)
Class II obese 3.55 (1.69) 2.66 (1.10) 3.22 (4.44) 2.94 (2.04) 1.70 (8.51) 2.43 (4.33) 2.97 (0.77)
Class III obese 3.36 (2.66) 3.59 (1.60) 2.66 (8.02) 3.60 (2.51) 2.91 (11.35) 3.88 (3.57) 3.49 (1.12)
Overall 3.11 (0.36) 2.54 (0.27) 3.59 (0.91) 3.19 (0.60) 2.87 (1.14) 2.40 (0.87) 2.86 (0.18)
60+ Underweight 0.84 (2.27) 0.32 (0.62) – (–) 1.07 (2.59) 7.43 (8.42) 0.30 (2.60) 0.33 (0.56)
Normal-weight 0.88 (0.37) 0.27 (0.18) 1.48 (0.99) 0.99 (0.60) 1.15 (1.28) 1.15 (0.79) 0.47 (0.16)
Overweight 1.05 (0.35) 0.51 (0.23) 1.03 (0.93) 0.80 (0.65) 1.40 (1.51) 0.75 (1.18) 0.67 (0.19)
Class I obese 1.33 (0.74) 0.85 (0.39) 1.79 (1.83) 1.38 (0.92) 2.09 (3.27) 1.88 (2.19) 1.05 (0.31)
Class II obese 2.92 (1.69) 0.90 (0.88) 0.50 (5.22) 2.32 (1.71) 1.74 (4.48) 1.82 (7.38) 1.44 (0.72)
Class III obese 2.08 (2.99) 1.58 (1.31) 0.20 (5.35) 2.89 (3.26) – (–) – (–) 1.86 (1.04)
Overall 1.31 (0.23) 0.62 (0.14) 1.38 (0.62) 1.45 (0.38) 1.29 (0.88) 1.33 (0.61) 0.89 (0.10)
Overall 2.67 (0.16) 0.79 (0.11) 3.45 (0.35) 2.25 (0.22) 3.39 (0.55) 2.11 (0.35) 1.58 (0.08)
Notes: a. Bootstrapping means and standard errors in parentheses are presented; –: no observations in the sample.
doi:10.1371/journal.pone.0066550.t002
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reported that they had no more than 12 drinks of any type of
alcoholic beverage in their entire life, and more than half of the
sample engaged in vigorous or moderate physical activity for 10
minutes at least once per week.
Life Years Lost Associated with ORDs
Figure 1 presents the patterns of life years lost associated with
ORDs for U.S. white and black, male and female, non-smoking
adults who were at least overweight. Table 2 shows life years lost
associated with ORDs for all race-gender-age-BMI classification
cohorts of U.S. non-smoking adults. In general, the younger an
adult developed ORDs, the more life years were lost associated
with the comorbidities. For blacks and whites who were
overweight or obese, ORDs were expected to decrease life years
from 5.20 (overweight white female) to 11.65 (class III obese black
male) for people under 29 years of age, while ORDs were expected
to decrease life years from 0.20 (class III obese black male) to 2.92
(class II obese white male) for people over 60 years of age (Table 2),
depending on degree of obesity, gender, and race.
ORDs appeared to decrease life years with increasing degree of
obesity. Overall, the class III obese lost 4.32 life years (from 0.20 to
11.65 life years across race-gender-age groups as shown in
Table 2); the class II obese lost 3.17 life years (from 0.5 to 9.69
life years); the class I obese lost about 2.17 life years (from 0.85 to
7.42 years); and the overweight lost 1.31 life years (from 0.51 to
7.25 life years, depending on their age, gender, and race).
In terms of gender and race, black males lost the most life years
to ORDs (3.45 years) across all ages and all degrees of obesity,
followed by males other than blacks and whites (3.39 years), white
males (2.67 years), black females (2.25 years), females other than
blacks and whites (2.11 years), and, lastly, white females (0.79
years). ORDs appeared to lessen the most life years of class III
obese black males aged 40 years and under (11.65 years for ages
29 and below and 6.29 years for ages 30 to 39).
The pattern of the predicted life years lost associated with
ORDs in the sensitivity analysis was only marginally different from
the main analysis (Table 2), though most of the standard errors in
sensitivity analysis were larger. We present the sensitivity results in
Table S3 in Appendix S1.
Hazard Ratios for Death
Figure 2 shows the marginal effects of ORDs on hazard rate. An
additional ORD was associated with an increase in risk of death
for every age group, though mortality risk was more severe for
younger individuals: 5.11 [95% CI: 3.85–6.79] for ages 20 to 29;
3.05 [95% CI: 2.31–4.02] for ages 30 to 39; 2.49 [95% CI: 2.09–
2.98] for ages 40 to 49; 2.07 [95% CI: 1.71–2.50] for ages 50 to
59; 1.87 [95% CI: 1.63–2.14] for ages 60 to 69; and 1.34 [95% CI:
1.24–1.44] for ages 70 and above.
To compare with those in previous studies, the hazard ratios for
death for each BMI classification were computed (see the
parameter estimates for each BMI classification in the final model
in Table S2 in Appendix S1). We found that the underweight, class
II, and class III obese had higher mortality rates than the normal-
weight (Figure 3). The class III obese had the highest hazard ratio
(1.69 [95% CI: 1.37–2.08]) compared to normal-weight people,
followed by the underweight (1.54 [95% CI: 1.39–1.70]), and the
class II obese (1.28 [95% CI: 1.14–1.44]). The overweight (0.90
[95% CI: 0.84–0.96]) and class I obese (0.997 [95% CI: 0.91–
1.09]) had lower death rates than the normal-weight, but the latter
was not statistically significant.
Discussion
We investigated the relationship between ORDs and mortality
by using the MPH model controlling for both observed and
unobserved individual heterogeneity. Using data from NHIS 1997
to 2000 and NHIS Linked Mortality Files to estimate the
parameters in the MPH model, we predicted life years lost
associated with ORDs based on the estimates in the model, using
simulated race-gender-age-BMI classification-ORD status cohorts
of U.S. non-smoking adults.
We confirmed that non-smoking adults with ORDs had higher
mortality. Depending on the age group, an additional ORD
increased risk of death by a range of 34% to 411%. This finding is
consistent with Kuk et al. [28], who used the Edmonton Obesity
Staging System (EOSS) to measure ORDs and found that the
hazard rate for people at stage 2 of EOSS was 119% higher than
the hazard rate for people at stage 1, and the hazard rate for
people at stage 3 of EOSS was 35% higher than the hazard rate
for people at stage 2. However, a direct comparison is difficult
because the data, models, and measurements of ORDs are
different.
Comparing and contrasting our study with previous studies that
explored the relationship between BMI/obesity and mortality and
took ORDs into account, we found that adults who belonged to
overweight and class I obese classifications had lower mortality
rates, while adults who belonged to underweight, class II and III
obese classifications had higher mortality rates than normal-weight
people, other things being equal. Consistent with previous findings
in the literature [20,21,23,26,56], our findings showed that higher
degrees of obesity and underweight were associated with higher
mortality. But deviating from Berrington de Gonzalez et al. [20]
and others [19,21], our BMI-mortality association approximated a
U-shaped relationship with the lowest mortality rate in the
overweight classification [23,24,26,56], while theirs approximated
Figure 2. Marginal effect of obesity-related diseases on
mortality rate for each age group.
doi:10.1371/journal.pone.0066550.g002
Figure 3. Hazard ratios for death for each BMI classification
(reference: the normal-weight).
doi:10.1371/journal.pone.0066550.g003
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a J-shaped relationship with the lowest mortality rate in the
normal-weight classification. This deviation can be explained by at
least three reasons: (i) our study adjusted for ORDs, and hence, the
nadir for death rates shifted slightly to the right in the range of
overweight; (ii) only whites were included in the sample of
Berrington de Gonzalez et al. [20], eliminating ethnic variation,
which is known to be a key determinant of obesity-mortality
relationships; (iii) unobserved heterogeneity was not controlled for
in their analyses; thus, the sample was selected toward survivors.
The predicted life years lost associated with ORDs decreased
with age. ORDs were expected to shorten the lifespan of people in
their 20 s by more than 5 years, while people in their 60 s were
predicted to lose just under 1 year of life. Fontaine et al. [14] also
found a similar trend in the context of life years lost to obesity.
Using U.S. non-smoking adults aged 40 to 49 years as an example
to illustrate percentage of the life years lost associated with ORDs,
we found that on average a 45-year-old U.S. non-smoking class III
obese black male with ORDs (compared with his counterpart
without ORDs) was expected to lose 5.43 years of life, which
translates to a 7.5% reduction in the total life years (72.78 years).
Of the same age and same degree of obesity, white males lost 5.23
life years (a 6.8% reduction in total life years), followed by black
females (5.04 years, a 6.5% reduction in life years), and white
females (4.70 years, a 5.8% reduction in life years). The total life
years were obtained by averaging 4-year life expectancy for the
target populations from the U.S. Life Tables [57–60]. Based on
these average life years lost estimates, total life years lost associated
with ORDs for U.S. non-smoking adults aged 40 to 49 years was
estimated to be 914,573 for white males (n = 174,821); 1,324,105
for white females (n = 281,679); 189,847 for black males
(n = 34,967); and 501,745 for black females (n = 99,556).
The predicted life years lost associated with ORDs also
increased with degree of obesity. Although our final model did
not directly support the finding that the death rates associated with
ORDs were increasing with the degree of obesity, this increase was
possibly driven by the fact that ORDs were more prevalent in
people with higher degrees of obesity, and an increased risk of
mortality was associated with an additional ORD (Figure 2).
Our analysis has several strengths. First, our analysis focused on
ORDs and examined their association with mortality and life
years, an association that has not been well studied. Second, unlike
most studies, our study controlled for unobserved heterogeneity,
which captures the effects of unavailable variables in the data; as a
result, our estimations are more precise, and our prediction of life
years lost associated with ORDs is more reliable. Third, we
incorporated the degree of obesity confounding the analysis when
exploring the relationship between ORDs and mortality. Overall,
this study not only advances in methodology, but provides a
different perspective on the relationship between ORDs and
mortality, which will inform the future analyses of any weight-loss
intervention, ranging from physical activity programs to bariatric
surgery, including, but not limited to, cost-effectiveness analyses.
Yet, our study has several limitations. First, using ORD counts
prevented us from differentiating the effects of different diseases.
Second, due to data constraints, the ORDs this paper targeted
were a subset of obesity-related comorbidities. Third, the data that
we used are cross-sectional, and our model is not time-varying and
does not capture the dynamics of disease evolution, which limits its
projection capability on life years lost [46]. For example, smoking
status might change over time for the younger cohorts in
particular, which could add variation to the relationships. Fourth,
some studies [61–63] suggest that different weight predictors of
mortality, e.g., waist-hip ratio, waist circumference, or fitness,
might be better measures than BMI. Even if they are not,
incorporating them would have made the analysis more compre-
hensive. However, these data were not available in the NHIS
datasets.
Conclusion
Our results confirm that being obese or underweight increased
risk of mortality. Furthermore, our study suggests that the ORDs
included in our study – coronary heart disease, hypertension,
diabetes, and stroke – increased chances of dying and decreased
life years by 0.2 to 11.7 years depending on gender, race, BMI
classification, and age. The life years lost associated with ORDs
was more pronounced for younger, black, male, and more obese
adults than for older, white, female, and less obese adults.
This conclusion not only conveys a message that these
populations are more vulnerable to ORDs, but it also informs
policy makers that public health initiatives should put more
emphasis on the prevention of obesity and obesity-related
comorbidities for these populations. More importantly, future
studies should investigate how different ORDs separately observed
at different life stages impact life years lost.
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